It all started in the lab. Two Boston University doctoral students, Joshua McGee and Jack Kirsch, were creating and testing ...

The technique is called in vivo CAR-M therapy. "The nomination of the two autoimmune targets is a significant milestone in ...

An accidental discovery turned into an unexpected success when a team of interdisciplinary BU researchers created a new and ...

RNA vaccines are just the tip of the iceberg. Ruby Jackson discusses how this versatile molecule is revolutionising medicine ...

An innovative approach to healthcare, precision medicine is a new medical model that takes into account individual ...

Scientists from Spirovant Sciences describe SP-101, a novel adeno-associated virus (AAV) gene therapy for the treatment of ...

The mRNA both serves as a template for protein ... lentiviruses and foamy viruses have been used for gene-therapy approaches. Since studies with foamy viruses are still in the preclinical phase ...

This article discusses the journeys of three gene therapy startups in South Korea, Japan, and China, and the products they ...

Analyst Thomas Smith of Leerink Partners maintained a Buy rating on Cartesian Therapeutics (RNAC – Research Report), retaining the price ...

H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating on Cartesian Therapeutics (RNAC – Research Report) today and set a price ...

After an initial defeat against the biggest barrier to mRNA flu vaccines—namely, B strains of influenza—GSK has returned with a reformulated candidate that has delivered the goods in the all ...

Minister for Economic Growth Tim Pallas has announced the latest grant recipients of the Victorian Government’s mRNA Victoria ...